Evoke raises $25.2 million in IPO

Gastrointestinal disease company Evoke Pharma Inc. (NASDAQ:EVOK) raised $25.2 million through the sale of 2.1 million shares at $12 in an IPO at the low end of its proposed range. The $12 price valued the company at $69.4 million. Late last month, Evoke said it planned to sell 2.1 million shares at $12-$14. Aegis Capital; Cantor Fitzgerald; and Feltl are underwriters. Evoke was off $0.26 to $11.74 in its first day of trading on Wednesday. ...